Filing Flows › Neuraxis (NRXS) › Q3 2025
Neuraxis (NRXS) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 10, 2025
Neuraxis (NRXS) reported revenue of $811K for the third quarter 2025 (Q3 2025), +22% from a year earlier and -9% from the quarter before. Operating margin was -258.8%, net loss $2.1M (261.6% of revenue).
Neuraxis, Q3 2025: revenue $811K (+22% year over year), operating margin -258.8%, net loss $2.1M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $811K | -9% | +22% |
| Operating profit | −$2.1M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $811K in Q3 2025, up 22% year over year and down 9% from the previous quarter.
Gross margin was 83.3%, down 2.1 points from a year earlier. Operating costs exceeded revenue by $2.1M, an operating margin of -258.8%. Operating expenses grew 25% against revenue growth of 22%. The fastest-growing cost line was Sales & marketing (+125%). The quarter ended with a net loss of $2.1M, wider than the previous quarter's $1.7M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $16K of depreciation and amortization and $161K of share-based compensation. Working capital and other items added $518K.
Questions
What was Neuraxis' revenue in the third quarter 2025?
Neuraxis (NRXS) reported revenue of $811K for the third quarter 2025 (Q3 2025), +22% from a year earlier and -9% from the quarter before.
Was Neuraxis profitable in the third quarter 2025?
Operating loss was $2.1M (-258.8% of revenue) and net loss $2.1M.
Source: Neuraxis 10-Q on SEC EDGAR.